Conference Coverage

Calorie counting and exercise ‘of limited value’ for obesity weight loss


 

FROM ECO 2022

Exercise and restricted diet

Notably, while exercise and calorie-controlled or restricted diets were among the most popular weight-loss methods in U.K. participants, they were amongst the least successful strategies. For instance, while 26.5% of adults who controlled their diet said they had lost weight, 17.1% reported their weight had increased. For those who took part in an exercise program, 33.3% said they lost weight, but 15.5% said they gained weight.

Signing up for gym membership also scored poorly, with 27% shedding weight, compared with 32.4% who put weight on.

“Our survey results indicate that, while the majority of adults with obesity are actively trying to reduce their weight, using a variety of strategies, most are unsuccessful,” said Dr. Evans.

Further studies were needed to assess whether people who lose weight succeed in maintaining their weight loss, the authors said.

The conference posters have yet to be published in a journal but were peer reviewed by the ECO selection committee.

The studies were sponsored by Novo Nordisk, a researcher into and manufacturer of diabetes and obesity medications, and employer of several of the coauthors.

A version of this article first appeared on Medscape UK/Univadis.

Pages

Recommended Reading

Be aware of gallbladder, biliary disease with newer obesity drugs
MDedge Internal Medicine
Obesity increasing the risk for cancer: It’s complicated
MDedge Internal Medicine
Type 2 diabetes remission possible for those with lower BMI
MDedge Internal Medicine
AHA statement addresses CVD risk in NAFLD
MDedge Internal Medicine
Bariatric surgery cuts cardiovascular events, even in seniors
MDedge Internal Medicine
Study: Fasting plus calorie counting offered no weight-loss benefit over calorie counting alone
MDedge Internal Medicine
Endoscopic obesity treatments offer alternatives to surgery
MDedge Internal Medicine
It’s time to shame the fat shamers
MDedge Internal Medicine
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
MDedge Internal Medicine
New research holds promise for fighting obesity, says expert
MDedge Internal Medicine